Page 27 - Central Drug Authority Annual Report 2021
P. 27

5. FUNCTIONING OF THE CDA


             7KH &'$ IXQFWLRQHG WKURXJK LWV ([HFXWLYH &RPPLWWHH DQG   6RPH  VXFFHVV  ZDV  DFKLHYHG  LQ  WKH  DQQXDO  VHDVRQDO
             IRXU 6XE FRPPLWWHHV  7KH ([HFXWLYH &RPPLWWHH ZDV PDGH   PDUNHWLQJ  FDPSDLJQV  VXUURXQGLQJ  WKH  PDMRU  KROLGD\V
             up of Chairperson, Deputy Chairperson, Chairpersons of   WKURXJK WKH OLQNV FUHDWHG EHWZHHQ GHVLJQDWHG PHPEHUV RI
             6XE FRPPLWWHHV DQG 'HSXW\ &KDLUSHUVRQV RI 6XE FRPPLW-  WKH &'$ DQG WKH 'HSDUWPHQW RI 6RFLDO 'HYHORSPHQW  DV ZHOO
             tees.                                             DV WKH VXSSRUWLQJ VWDNHKROGHUV  YLD D YDULHW\ RI YLVLWV WR DQG
             7KH FRPPLWWHHV RI WKH &'$ ZHUH DV IROORZV         SUHVHQWDWLRQV PDGH WR GHSDUWPHQWV DQG WR RWKHU UHOHYDQW
               ȧ  *RYHUQDQFH &RPPLWWHH                         VWDNHKROGHUV  ,Q DGGLWLRQ  WKH &'$ SDUWLFLSDWHG LQ D YDULHW\ RI
               ȧ  &RPPXQLFDWLRQV DQG 0DUNHWLQJ &RPPLWWHH       IRUPDO HYHQWV DUUDQJHG E\ WKH QDWLRQDO GHSDUWPHQW DQG LQ
               ȧ  5HVHDUFK DQG 'DWDEDVH &RPPLWWHH              FRQMXQFWLRQ  ZLWK  WKHP  WR  FRQYH\  D  YDULHW\  RI  PHVVDJHV
                                                               DERXW WKH VXEVWDQFH DEXVH SUREOHP
               ȧ  3URMHFWV DQG 3URJUDPV &RPPLWWHH
                                                               $OWKRXJK QRW SDUW RI WKH PDQGDWH RI WKH &RPPXQLFDWLRQV
             a)  Research and Database Committee
                                                               DQG 0DUNHWLQJ &RPPLWWHH  LW ZDV QRWLFHDEOH WKDW WKH &'$
                                                               KDG RQO\ WZR RU WKUHH RSSRUWXQLWLHV WR ȟDGYLVH WKH 0LQLVWHUȠ
             7KH  UHVHDUFK  FRPPLWWHH  RI  WKH  &'$  LV  WDVNHG  ZLWK  WKH   DV UHTXLUHG E\ WKH $FW DQG LQ WKDW  FDQ EH FRQVLGHUHG WR KDYH
             RYHUDOO UHVHDUFK FRQVROLGDWLRQ DQG FKDPSLRQLQJ LQ WKH ˉHOG   EHHQ OHVV WKDQ VXFFHVVIXO
             RI  VXEVWDQFH  DEXVH  LQ  WKH  FRXQWU\   7KH  &'$  PXVW  HLWKHU
             FROODERUDWH  ZLWK  RWKHU  SDUWQHUV  RU  FRPPLVVLRQ  UHVHDUFK   ,W LV ZRUWK QRWLQJ WKDW  ZLWK WKH H[FHSWLRQ RI WKH &HOO 3KRQH
             ZKLFK FRXOG LQFOXGH DPRQJVW RWKHUV  KRXVHKROG VXUYH\V DQG   6KRUW  0HVVDJH  6HUYLFH   606   FDPSDLJQ   XVH  ZDV  PDGH
             WUHQG DQDO\VHV RI WKH GUXJ SUREOHP LQ WKH FRXQWU\  7KH &'$   SULPDULO\  RI  FRQYHQWLRQDO  PHDQV  RI  FRPPXQLFDWLRQ   L H
             PXVW DOVR HVWDEOLVK GDWD OLQNV ZLWK FHUWDLQ QDWLRQDO GHSDUW-  VSHDNHUV   SRVWHUV   QHZVSDSHU  DGYHUWLVHPHQWV   HWF     ZKLOVW
             PHQWV  WR IDFLOLWDWH PRQLWRULQJ  UHSRUWLQJ DQG FRRUGLQDWLRQ    WKH  PRUH  WHFKQRORJLFDOO\  DGYDQFHG  PHWKRGV   L H    ZHEVLWH
             7KLV KDV QRW EHHQ DFKLHYHG  'DWD OLQNV KDYH WR D YHU\ OLPLWHG   )DFHERRN  WZLWWHU  ,QVWDJUDP  <RX7XEH HWF   ZHUH QRWLFHDEO\
             H[WHQW  EHHQ HVWDEOLVKHG ZLWK FHUWDLQ QDWLRQDO GHSDUWPHQWV   DEVHQW
             EXW WKLV KDV QRW EHHQ DGHTXDWHO\ H[SORLWHG
                                                               7KH  DFWLYLWLHV  LQGLFDWHG  DERYH  ZHUH  QRW  SODQQHG  E\  WKH
             2QH RI WKH UHVSRQVLELOLWLHV RI WKLV FRPPLWWHH LV WKH HVWDE-  &RPPLWWHH  +RZHYHU  LQGLYLGXDO PHPEHUV ZRXOG EH LQYLWHG
             OLVKPHQW RI D QDWLRQDO FOHDULQJ KRXVH  D VPDOO OLEUDU\  RU D   WR SDUWLFLSDWH LQ WKHVH DFWLYLWLHV  (VVHQWLDOO\  WKH &RPPLWWHH
             UHSRVLWRU\ RI GDWD RQ VXEVWDQFH DEXVH WKDW ZLOO HQDEOH WKH   ZDV QRW IXQFWLRQDO DQG QHYHU KDG PHHWLQJV LQ WKH SHULRG
             &'$ WR FROOHFW  DVVHVV  VWRUH  DQG GLVWULEXWH ERRNV  GRFXPHQWV   XQGHU UHYLHZ
             DQG LQIRUPDWLRQ WKDW FDQ EH XVHG E\ LQWHUHVWHG SDUWLHV DQG
             DFFHVVHG  SK\VLFDOO\  RU  HOHFWURQLFDOO\   :KLOVW  WKH  FOHDULQJ
             KRXVH  ZDV  SUHYLRXVO\  HVWDEOLVKHG  DW  WKH  QDWLRQDO  'HSDUW-  c) Governance Committee
             PHQW RI 6RFLDO 'HYHORSPHQW  LWV H[LVWHQFH LV QRW ZHOO NQRZQ
             DQG WKH H[WHQW RI LWV XWLOLVDWLRQ KDV QRW EHHQ GHWHUPLQHG   7KLV &RPPLWWHH KDV EHHQ D VWUDWHJLF GULYHU RI WKH ZRUN RI
                                                               WKH  &'$   PDNLQJ  VXUH  WKDW  VWDWXWRU\  REOLJDWLRQV  DQG
                                                               UHTXLUHPHQWV DUH PHW
             )RU  WKLV  FRPPLWWHH  WR  IXQFWLRQ  RSWLPDOO\   WKHUH  PXVW  EH
             RSWLPDO  SURYLVLRQ  RI  UHVRXUFHV  IRU  LWV  IXQFWLRQV  7KH  GUXJ
             SUREOHP  LV  UHDFKLQJ  HQGHPLF  SURSRUWLRQV  DQG  ZLWKRXW   7KH &RPPLWWHH KDV EHHQ DEOH WR DFKLHYH WKH IROORZLQJ
             LQYHVWPHQW  LQ  UHVHDUFK   WKH  H[WHQW  RI  WKH  SUREOHP  DQG      &RPSLOLQJ WKH &'$ $QQXDO 5HSRUW IRU WKH SHULRG
             DSSURSULDWH HYLGHQFH EDVHG WUHDWPHQW ZLOO QRW EH UHDOLVHG              DV UHTXLUHG E\ WKH $FW
                                                                     )DFLOLWDWLQJ WKH ODXQFK RI WKH 1'03
             This Committee was not functional in the year under review.
                                                               d) Projects and Programmes Committee
             b)  Communications and Marketing Committee
                                                               7KLV &RPPLWWHH ZDV QRW IXQFWLRQDO LQ WKH \HDU XQGHU UHYLHZ
             7KH FRPPXQLFDWLRQ DQG PDUNHWLQJ SODQ RI WKH &'$ ZDV QRW
             HQWLUHO\ VXFFHVVIXO IRU D YDULHW\ RI UHDVRQV LQFOXGLQJ D VKRUW-
             DJH  RI  IXQGV   LQDGHTXDWH  RUJDQLVDWLRQDO  OLQNV  ZLWK  RWKHU
             VWUDWHJLF SOD\HUV  LQFOXGLQJ WKH GHSDUWPHQWDO FRPPXQLFD-
             WLRQV  VWUXFWXUH   LQ  WKH  FRPPXQLFDWLRQ  ˉHOG   D  ODFN  RI
             IXOO WLPH SHUVRQQHO DQG ODVW PLQXWH QRWLˉFDWLRQ RI D ODFN RI
             DXWKRULW\ DQG RU IXQGV


                                       Annual Report 2020/2021 Central Drug Authority                           25
   22   23   24   25   26   27   28   29   30   31   32